Stockreport

Immunomedics up 29% in postmarket resumption [Seeking Alpha]

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF Immunomedics (NASDAQ:IMMUFDA gave approvalThe shares ended the postmarket sessionup 29.2%The $28.38 quoted after hours would mark a 20-year high for the stock, which las [Read more]